Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2002 45
2003 77
2004 49
2005 32
2006 54
2007 51
2008 27
2009 29
2010 18
2011 20
2012 15
2013 12
2014 15
2015 21
2016 19
2017 32
2018 16
2019 14
2020 8
2021 8
2022 4
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

520 results

Results by year

Filters applied: . Clear all
Page 1
Wnt/beta-catenin pathway: modulating anticancer immune response.
Pai SG, Carneiro BA, Mota JM, Costa R, Leite CA, Barroso-Sousa R, Kaplan JB, Chae YK, Giles FJ. Pai SG, et al. Among authors: giles fj. J Hematol Oncol. 2017 May 5;10(1):101. doi: 10.1186/s13045-017-0471-6. J Hematol Oncol. 2017. PMID: 28476164 Free PMC article. Review.
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
Thomas DA, Faderl S, O'Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, Giles FJ, Verstovsek S, Wierda WG, Pierce SA, Shan J, Brandt M, Hagemeister FB, Keating MJ, Cabanillas F, Kantarjian H. Thomas DA, et al. Among authors: giles fj. Cancer. 2006 Apr 1;106(7):1569-80. doi: 10.1002/cncr.21776. Cancer. 2006. PMID: 16502413 Free article. Clinical Trial.
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ. Kantarjian H, et al. Among authors: giles f. Cancer. 2004 Dec 15;101(12):2788-801. doi: 10.1002/cncr.20668. Cancer. 2004. PMID: 15481055 Free article. Clinical Trial.
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.
Kumthekar P, Ko CH, Paunesku T, Dixit K, Sonabend AM, Bloch O, Tate M, Schwartz M, Zuckerman L, Lezon R, Lukas RV, Jovanovic B, McCortney K, Colman H, Chen S, Lai B, Antipova O, Deng J, Li L, Tommasini-Ghelfi S, Hurley LA, Unruh D, Sharma NV, Kandpal M, Kouri FM, Davuluri RV, Brat DJ, Muzzio M, Glass M, Vijayakumar V, Heidel J, Giles FJ, Adams AK, James CD, Woloschak GE, Horbinski C, Stegh AH. Kumthekar P, et al. Among authors: giles fj. Sci Transl Med. 2021 Mar 10;13(584):eabb3945. doi: 10.1126/scitranslmed.abb3945. Sci Transl Med. 2021. PMID: 33692132 Free PMC article. Clinical Trial.
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors.
Patel SP, Othus M, Chae YK, Giles FJ, Hansel DE, Singh PP, Fontaine A, Shah MH, Kasi A, Baghdadi TA, Matrana M, Gatalica Z, Korn WM, Hayward J, McLeod C, Chen HX, Sharon E, Mayerson E, Ryan CW, Plets M, Blanke CD, Kurzrock R. Patel SP, et al. Among authors: giles fj. Clin Cancer Res. 2020 May 15;26(10):2290-2296. doi: 10.1158/1078-0432.CCR-19-3356. Epub 2020 Jan 22. Clin Cancer Res. 2020. PMID: 31969335 Free PMC article. Clinical Trial.
Is Personalized Medicine Here?
Carneiro BA, Costa R, Taxter T, Chandra S, Chae YK, Cristofanilli M, Giles FJ. Carneiro BA, et al. Among authors: giles fj. Oncology (Williston Park). 2016 Apr;30(4):293-303, 307. Oncology (Williston Park). 2016. PMID: 27085327 Free article. Review.
Overcoming immunosuppression in bone metastases.
Reinstein ZZ, Pamarthy S, Sagar V, Costa R, Abdulkadir SA, Giles FJ, Carneiro BA. Reinstein ZZ, et al. Among authors: giles fj. Crit Rev Oncol Hematol. 2017 Sep;117:114-127. doi: 10.1016/j.critrevonc.2017.05.004. Epub 2017 May 12. Crit Rev Oncol Hematol. 2017. PMID: 28600175 Review.
The role of inflammation in leukaemia.
Giles FJ, Krawczyk J, O'Dwyer M, Swords R, Freeman C. Giles FJ, et al. Adv Exp Med Biol. 2014;816:335-60. doi: 10.1007/978-3-0348-0837-8_13. Adv Exp Med Biol. 2014. PMID: 24818729 Review.
Novel therapies for myelofibrosis.
Stein BL, Cervantes F, Giles F, Harrison CN, Verstovsek S. Stein BL, et al. Among authors: giles f. Leuk Lymphoma. 2015;56(10):2768-78. doi: 10.3109/10428194.2015.1037762. Epub 2015 May 18. Leuk Lymphoma. 2015. PMID: 25860240 Free PMC article. Review.
Hairy cell leukemia.
Swords R, Giles F. Swords R, et al. Among authors: giles f. Med Oncol. 2007;24(1):7-15. doi: 10.1007/BF02685898. Med Oncol. 2007. PMID: 17673807 Review.
520 results